PFIZER
Back to Income Statement
|
PFIZER Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,281 Cr | ₹2,193 Cr | ₹2,425 Cr | ₹2,611 Cr | ₹2,239 Cr |
What is the latest Revenue of PFIZER ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,281 Cr |
| Mar2024 | ₹2,193 Cr |
| Mar2023 | ₹2,425 Cr |
| Mar2022 | ₹2,611 Cr |
| Mar2021 | ₹2,239 Cr |
How is Revenue of PFIZER Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,281 Cr | 4.02 | |
| Mar2024 | ₹2,193 Cr | -9.55 | |
| Mar2023 | ₹2,425 Cr | -7.13 | |
| Mar2022 | ₹2,611 Cr | 16.64 | |
| Mar2021 | ₹2,239 Cr | - | |
Compare Revenue of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,001.9 Cr | -2.2% | -9.1% | -4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -2.2% |
-9.1% |
-4.2% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses